Nephrectomy, Partial: Multimedia

References

1. Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. Aug 2002;168(2):454-9. [Medline].

2. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. Oct 1999;162(4):1282-4; discussion 1284-5. [Medline].

3. Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. Sep 1999;17(9):2868-75. [Medline].

4. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. Feb 2000;163(2):442-5. [Medline].

5. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. Sep 2006;7(9):735-40. [Medline].

6. Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol. Jul 1994;152(1):39-42. [Medline].

7. Kletscher BA, Qian J, Bostwick DG, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol. Mar 1995;153(3 Pt 2):904-6. [Medline].

8. Van Poppel H, Bamelis B, Oyen R, Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol. Sep 1998;160(3 Pt 1):674-8. [Medline].

9. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. Dec 2000;75(12):1236-42. [Medline].

10. Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol. Feb 2000;163(2):426-30. [Medline].

11. Dechet CB, Blute ML, Zincke H. Nephron sparing surgery for unilateral renal cell carcinoma: which variables contribute to contralateral recurrence?. J Urol. 1998;159:169 A.

12. Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology. Oct 2003;62(4):641-6. [Medline].

13. Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. Jul 2003;170(1):64-8. [Medline].

14. Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA. Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol. Mar 2008;53(3):514-23. [Medline].

15. Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology. Nov 2004;64(5):914-8. [Medline].

16. Gill IS, Novick AC, Meraney AM, Chen RN, Hobart MG, Sung GT, et al. Laparoscopic renal cryoablation in 32 patients. Urology. Nov 1 2000;56(5):748-53. [Medline].

17. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol. May 1997;157(5):1852-3. [Medline].

18. Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. Jan 1995;45(1):34-40; discussion 40-1. [Medline].

19. Campbell SC, Novick AC, Streem SB, Klein E, Licht M. Complications of nephron sparing surgery for renal tumors. J Urol. May 1994;151(5):1177-80. [Medline].

20. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. Jul 2004;172(1):63-5. [Medline].

21. Gill IS, Hsu TH, Fox RL, Matamoros A, Miller CD, Leveen RF, et al. Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology. Aug 1 2000;56(2):197-200. [Medline].

22. Hafez KS, Novick AC, Butler BP. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol. Apr 1998;159(4):1156-60. [Medline].

23. Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Positron emission tomography in urological oncology. J Urol. Feb 1998;159(2):347-56. [Medline].

24. Lang EK. Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma. Cancer. Nov 15 1984;54(10):2205-14. [Medline].

25. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. Jun 1996;155(6):1868-73. [Medline].

26. Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol. Oct 1990;144(4):852-7; discussion 857-8. [Medline].

27. Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol. Feb 2000;163(2):431-3. [Medline].

28. Russo P. Open partial nephrectomy: an essential contemporary operation. Nat Clin Pract Urol. Jan 2006;3(1):2-3. [Medline].

29. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. Jun 1995;153(6):1812-6. [Medline].

30. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. Jul 2001;166(1):6-18. [Medline].

31. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. Dec 1995;154(6):2010-4; discussion 2014-5. [Medline].

32. Zincke H, Ghavamian R. Partial nephrectomy for renal cell cancer is here to stay--more data on this issue. J Urol. Apr 1998;159(4):1161-2. [Medline].

Further Reading

For more information, see Medscape’s Renal Cell Carcinoma Resource Center.

Keywords

nephron-sparing surgery, NSS, RCC, renal cell carcinoma, renal parenchymal-sparing surgery, partial nephrectomy, radical nephrectomy, synchronous bilateral tumors, tumors in a solitary kidney, poorly functional contralateral renal unit, renal lesions, renal tumors, renal oncocytoma, renal angiomyolipoma, renal multilocular cyst, renal-preserving surgery, nephron-preserving surgery, hereditary papillary renal cell carcinoma, hereditary papillary RCC, von Hippel-Lindau syndrome, VHL syndrome, cystic renal neoplasm, solid renal neoplasm

Contributor Information and Disclosures

Author

Reza Ghavamian, MD, Director, Associate Professor, Department of Urology, Section of Urologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine
Reza Ghavamian, MD is a member of the following medical societies: American Urological Association and Society of Urologic Oncology
Disclosure: Nothing to disclose.

Coauthor(s)

Horst Zincke, MD, PhD, Professor, Department of Urology, Mayo Medical School
Horst Zincke, MD, PhD is a member of the following medical societies: American Medical Association, Minnesota Medical Association, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College
Michael Grasso, MD is a member of the following medical societies: American Medical Association, American Urological Association, California Medical Association, and Endourological Society
Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Boston Scientific Consulting fee Consulting; Cook Urologic Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Martin I Resnick, MD †, Former Lester Persky Professor and Chair, Department of Urology, Former Professor, Department of Oncology, Case Western Reserve University School of Medicine
Martin I Resnick, MD † is a member of the following medical societies: American College of Surgeons, American Federation for Medical Research, American Institute of Ultrasound in Medicine, American Medical Association, American Society for Bone and Mineral Research, American Society for Reproductive Medicine, American Society of Andrology, American Surgical Association, American Urological Association, Association for Academic Surgery, Endocrine Society, National Kidney Foundation, Ohio Urological Society, and Pan American Medical Association
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Gyrus-ACMI Honoraria Speaking and teaching

Chief Editor

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.